OCS-05 in Patients With Optic Neuritis
Trial details
- Registry ID
- NCT04762017
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| OCS-05 in Patients With Optic NeuritisNCT04762017 | Oculis | Phase 2 | Completed | 2024-09-16Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |